Skip to content
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology

Managing Digestion and Bladder Complications

At a Glance

Idiopathic peripheral autonomic neuropathy can slow digestion and impair bladder storage or emptying. Care usually combines targeted testing, small-meal or bowel strategies, catheterization when needed, and careful medication review to protect hydration, blood pressure, and kidney function.

When the autonomic nervous system’s “autopilot” fails in Idiopathic Peripheral Autonomic Neuropathy (IPAN) or Pure Autonomic Failure (PAF), the “glitches” often extend to how your body processes food and eliminates waste [1][2]. These symptoms—like severe bloating or bladder urgency—can be just as disruptive as blood pressure changes, but they require a different, system-specific management approach [1][3].

Managing Digestive “Glitches” (Dysmotility)

Because your nerves aren’t signaling your digestive tract to move predictably, food may sit too long in the stomach (gastroparesis) or move too slowly through the intestines (constipation) [4][5].

Diagnosis and Testing

Early fullness and bloating do not establish gastroparesis; objective diagnosis requires testing and exclusion of physical obstruction or other causes [4]. Tests help pinpoint the problem:

  • Gastric Emptying Scintigraphy: The gold-standard test where you eat a “tagged” meal to see how quickly your stomach empties [6].
  • Wireless Motility Capsule: A pill you swallow that measures pressure and transit time through your entire digestive tract [5][7].

Treatment Strategies

  • Dietary Shifts: Instead of three large meals, try 5-6 individualized small meals that are often lower in fat and insoluble fiber [4][8]. A dietitian with autonomic experience is invaluable here.
  • Prokinetic Medications: Drugs like metoclopramide or domperidone help “push” food through [9]. However, metoclopramide carries a serious risk of tardive dyskinesia (a persistent movement disorder), requiring strict duration limits and immediate reporting of any new tremors [9].
  • Constipation Relief: Newer drugs like prucalopride or linaclotide may be used alongside standard osmotic laxatives to improve colon transit [10]. However, these can cause diarrhea, which worsens dehydration and orthostatic symptoms.
  • Advanced Options: Specialist options for highly refractory disease may include endoscopic procedures (like G-POEM) or feeding tubes to ensure you stay hydrated and nourished [8][11].

Escalation Advice: Seek immediate medical care for an inability to urinate, fever or flank pain, severe abdominal pain, blood in your stool or urine, persistent vomiting, or inability to maintain hydration and nutrition.

Navigating Bladder Complications

Autonomic failure can cause two main bladder problems: failing to store urine (leading to urgency and accidents) or failing to empty urine (urinary retention) [12][13].

The Importance of Urodynamics

Initial assessment commonly includes history, urinalysis, and checking your post-void residual (PVR) (the amount of urine left after you go) [14]. Advanced urodynamics testing (measuring the pressures inside your bladder) is most important when the diagnosis is unclear, symptoms are complex or refractory, or high-pressure neurogenic bladder is suspected [15][16]. High pressures in the bladder can eventually damage your kidneys [17].

Treatment Options

  • Clean Intermittent Catheterization (CIC): If you are not emptying your bladder fully, CIC is often the first-line treatment [18]. It involves using a small, temporary tube to drain the bladder several times a day. This is often safer and more effective than long-term medications for retention [19].
  • Overactivity Medications: If your bladder is “squeezing” too often, drugs like mirabegron or antimuscarinics can help it relax [20][21]. However, mirabegron can raise blood pressure, and antimuscarinics can worsen urinary retention, severe constipation, and cognitive fogginess.
  • Botox Injections: For severe urgency that doesn’t respond to pills, Botox can be injected directly into the bladder wall [16][22]. This carries a high risk of causing urinary retention and urinary tract infections, and requires you to have a safe catheterization plan in place.

The Cross-System Trap: Medication Interactions

Managing multiple systems at once is tricky because a drug for one problem can worsen another.

  1. Bladder Meds and Blood Pressure: Many bladder-relaxing drugs can worsen orthostatic hypotension, making you more likely to faint when you stand [23].
  2. BP Meds and Bladder Retention: Drugs used to raise blood pressure, like midodrine, can sometimes tighten the bladder exit, making it even harder to urinate if you already have retention [24].
  3. The Dehydration Cycle: Diarrhea or vomiting from GI issues can cause you to lose fluids rapidly. This makes your blood pressure drop even further, creating an emergency situation where you cannot stay upright [25][26].

Always inform every specialist (Gastroenterologist, Urologist, and Neurologist) about every medication you are taking to avoid these conflicting effects. [27]

Common questions in this guide

Why does idiopathic peripheral autonomic neuropathy cause bloating and constipation?
Autonomic nerves help coordinate movement of the stomach and intestines. When those signals are impaired, food may remain in the stomach too long, causing early fullness, bloating, or nausea, while stool may move slowly and cause constipation. Symptoms alone do not prove gastroparesis; testing and exclusion of a blockage or another cause are needed.
Which tests can show whether digestion is slowing down?
Gastric emptying scintigraphy tracks a tagged meal to measure how quickly it leaves the stomach. A wireless motility capsule is a swallowed device that measures pressure and transit time through the digestive tract. A clinician may recommend one of these tests after considering an obstruction or another explanation for the symptoms.
What treatments can help digestive problems caused by autonomic neuropathy?
Small, frequent meals that are often lower in fat and insoluble fiber may be easier to tolerate than large meals. Medicines such as metoclopramide or domperidone may improve stomach movement, while prucalopride, linaclotide, or osmotic laxatives may help constipation. Metoclopramide can cause a persistent movement disorder, so its duration and new tremors or other movements require prompt medical review.
How can autonomic neuropathy affect bladder function?
It can cause the bladder to store urine poorly, leading to urgency or accidents, or to empty poorly, leading to urinary retention. A urinalysis and post-void residual measurement can show whether urine remains after urination. Urodynamics may be needed for complex or persistent symptoms and can help identify high bladder pressures that may harm the kidneys.
When is clean intermittent catheterization used for autonomic bladder problems?
Clean intermittent catheterization is commonly used when the bladder does not empty fully. A small temporary tube drains the bladder several times a day and is often safer and more effective than long-term medicine for retention. A healthcare professional should teach the technique and help create a safe schedule.
Can bladder medicines and blood pressure medicines interfere with each other?
Yes, different medicines can affect blood pressure, bladder emptying, and bowel function in opposite ways. Some bladder medicines may worsen orthostatic hypotension, mirabegron can raise blood pressure, and midodrine may make urination harder in someone with retention. Tell every specialist about all medicines, and report diarrhea or vomiting because fluid loss can sharply worsen low blood pressure.
When should I seek urgent care for digestive or bladder symptoms?
Seek immediate medical care for an inability to urinate, fever or flank pain, severe abdominal pain, blood in the stool or urine, persistent vomiting, or an inability to maintain hydration and nutrition. These symptoms can signal a complication that needs prompt assessment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Have I had a post-void residual (PVR) test to see if I am fully emptying my bladder?
  2. 2.Should we do a 'Wireless Motility Capsule' or gastric emptying study to see exactly where my digestion is slowing down?
  3. 3.If we start a medication for my bladder, how will we monitor if it makes my standing blood pressure even lower?
  4. 4.Is my current dose of midodrine or droxidopa potentially making it harder for me to urinate?
  5. 5.Are my frequent urinary tract infections (UTIs) caused by the fact that I'm not emptying my bladder completely?
  6. 6.Can you recommend a registered dietitian who has experience with autonomic dysmotility?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies.

    Lamotte G, Sandroni P

    Current neurology and neuroscience reports 2022; (22(12)):823-837 doi:10.1007/s11910-022-01240-4.

    PMID: 36376534
  2. 2

    Neuropathology of autonomic dysfunction in synucleinopathies.

    Coon EA, Cutsforth-Gregory JK, Benarroch EE

    Movement disorders : official journal of the Movement Disorder Society 2018; (33(3)):349-358 doi:10.1002/mds.27186.

    PMID: 29297596
  3. 3

    Gastrointestinal autonomic neuropathy in diabetes.

    Marathe CS, Jones KL, Wu T, et al.

    Autonomic neuroscience : basic & clinical 2020; (229()):102718 doi:10.1016/j.autneu.2020.102718.

    PMID: 32916479
  4. 4

    Diabetic Gastroparesis: Principles and Current Trends in Management.

    Krishnasamy S, Abell TL

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2018; (9(Suppl 1)):1-42 doi:10.1007/s13300-018-0454-9.

    PMID: 29934758
  5. 5

    Quantitative gastrointestinal function and corresponding symptom profiles in autonomic neuropathy.

    Langford JS, Tokita E, Martindale C, et al.

    Frontiers in neurology 2022; (13()):1027348 doi:10.3389/fneur.2022.1027348.

    PMID: 36588909
  6. 6

    Clinical insights into diabetic gastroparesis: gastric scintigraphy-based diagnosis and treatment outcomes.

    Wifi MN, El-Sherbiny M, Mohamed RS, et al.

    BMC gastroenterology 2025; (25(1)):640 doi:10.1186/s12876-025-03977-x.

    PMID: 40954450
  7. 7

    Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives.

    Kornum DS, Terkelsen AJ, Bertoli D, et al.

    Journal of clinical medicine 2021; (10(7)) doi:10.3390/jcm10071392.

    PMID: 33807256
  8. 8

    Diabetic Gastroparesis.

    Bharucha AE, Kudva YC, Prichard DO

    Endocrine reviews 2019; (40(5)):1318-1352 doi:10.1210/er.2018-00161.

    PMID: 31081877
  9. 9

    Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D2 /D3 receptor antagonist, in patients with gastroparesis.

    Kuo B, Scimia C, Dukes G, et al.

    Alimentary pharmacology & therapeutics 2021; (54(3)):267-280 doi:10.1111/apt.16451.

    PMID: 34148244
  10. 10

    Update on the Treatment of Autonomic Disorders.

    Eid AM, Vázquez-Vélez GE, Maliszewski B, et al.

    Current treatment options in neurology 2025; (27()) doi:10.1007/s11940-025-00830-0.

    PMID: 41404536
  11. 11

    Gastroparesis.

    Cangemi DJ, Lacy BE

    Current opinion in gastroenterology 2021; (37(6)):596-601 doi:10.1097/MOG.0000000000000782.

    PMID: 34560721
  12. 12

    The natural history of idiopathic autonomic failure: The IAF-BO cohort study.

    Giannini G, Calandra-Buonaura G, Asioli GM, et al.

    Neurology 2018; (91(13)):e1245-e1254 doi:10.1212/WNL.0000000000006243.

    PMID: 30135257
  13. 13

    Pure Autonomic Failure.

    Thaisetthawatkul P

    Current neurology and neuroscience reports 2016; (16(8)):74 doi:10.1007/s11910-016-0673-2.

    PMID: 27338613
  14. 14

    Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.

    Musco S, Padilla-Fernández B, Del Popolo G, et al.

    Neurourology and urodynamics 2018; (37(5)):1522-1540 doi:10.1002/nau.23501.

    PMID: 29392753
  15. 15

    Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.

    Medina-Polo J, Adot JM, Allué M, et al.

    Neurourology and urodynamics 2020; (39(2)):762-770 doi:10.1002/nau.24276.

    PMID: 31943361
  16. 16

    Early urological care of patients with spinal cord injury.

    Welk B, Schneider MP, Thavaseelan J, et al.

    World journal of urology 2018; (36(10)):1537-1544 doi:10.1007/s00345-018-2367-7.

    PMID: 29948046
  17. 17

    Surveillance and management of urologic complications after spinal cord injury.

    Kreydin E, Welk B, Chung D, et al.

    World journal of urology 2018; (36(10)):1545-1553 doi:10.1007/s00345-018-2345-0.

    PMID: 29845320
  18. 18

    Clean intermittent catheterization revisited.

    Lamin E, Newman DK

    International urology and nephrology 2016; (48(6)):931-9 doi:10.1007/s11255-016-1236-9.

    PMID: 26956983
  19. 19

    Application of clean intermittent catheterization for neurogenic bladder in infants less than 1 year old.

    Li Y, Wen Y, He X, et al.

    NeuroRehabilitation 2018; (42(4)):377-382 doi:10.3233/NRE-172366.

    PMID: 29660959
  20. 20

    The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis.

    Zhang D, Sun F, Yao H, et al.

    Frontiers in pharmacology 2021; (12()):756582 doi:10.3389/fphar.2021.756582.

    PMID: 34867373
  21. 21

    A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.

    Welk B, Hickling D, McKibbon M, et al.

    Neurourology and urodynamics 2018; (37(8)):2810-2817 doi:10.1002/nau.23774.

    PMID: 30168626
  22. 22

    Perspectives on urological care in multiple sclerosis patients.

    Moussa M, Abou Chakra M, Papatsoris AG, et al.

    Intractable & rare diseases research 2021; (10(2)):62-74 doi:10.5582/irdr.2021.01029.

    PMID: 33996350
  23. 23

    Orthostatic Hypotension in the Hypertensive Patient.

    Biaggioni I

    American journal of hypertension 2018; (31(12)):1255-1259 doi:10.1093/ajh/hpy089.

    PMID: 29982276
  24. 24

    Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report.

    Tran L, Brodeur M

    The Senior care pharmacist 2023; (38(12)):501-505 doi:10.4140/TCP.n.2023.501.

    PMID: 38041226
  25. 25

    Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.

    Palma JA, Gonzalez-Duarte A, Kaufmann H

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2019; (29(Suppl 1)):33-44 doi:10.1007/s10286-019-00623-x.

    PMID: 31452021
  26. 26

    How to treat cardiovascular autonomic failure in Parkinson's disease.

    Fanciulli A, Leys F, Höglinger G, Jost WH

    Journal of neural transmission (Vienna, Austria : 1996) 2026; (133(2)):215-228 doi:10.1007/s00702-025-03096-7.

    PMID: 41484430
  27. 27

    Management of Orthostatic Hypotension: A Review.

    Moloney D, Youssef A, Okamoto LE

    JAMA internal medicine 2026; doi:10.1001/jamainternmed.2026.0284.

    PMID: 41941194

This page is for informational purposes only and does not constitute medical advice about idiopathic peripheral autonomic neuropathy. Your neurologist, gastroenterologist, or urologist should guide testing, medication changes, diet, hydration, and catheter care.

Get notified when new evidence is published on idiopathic peripheral autonomic neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.